Search Results - "Zdrojowy, R"

Pharmacotherapy of patients with benign prostate enlargement and storage symptoms in everyday clinical practice by Zdrojowy, R, Owczarek, A J, Olszanecka-Glinianowicz, M, Almgren-Rachtan, A, Chudek, J

“…Storage symptoms significantly deteriorate the quality of life in men with benign prostate enlargement (BPE). Muscarinic receptor antagonists (MRAs) and…”
Get more information

Coping strategies and sexual satisfaction in bladder cancer males by Krajewski, W, Koscielska-Kasprzak, K, Szczesniak, D, Zdrojowy, R, Rymaszewska, J

Get full text

Uroplakin IIIa Is a Marker in Bladder Cancer but Seems Not to Reflect Chemical Carcinogenesis by Zdrojowy, Romuald, Dembowski, J., Matuszewski, M., Szymańska, B., Długosz, A.

“…Background. Uroplakins are glycoproteins investigated as potential markers of urothelial carcinoma. However, their role in chemical carcinogenesis is…”
Get full text

Is the Genetic Background of Co-Stimulatory CD28/CTLA-4 Pathway the Risk Factor for Prostate Cancer? by Karabon, Lidia, Tupikowski, K., Tomkiewicz, A., Partyka, A., Pawlak-Adamska, E., Wojciechowski, A., Kolodziej, A., Dembowski, J., Zdrojowy, R., Frydecka, I.

“…The impairment of immunological surveillance caused by aberrant T cell activation can lead to an inadequate anti-tumor response. Therefore, deregulation in…”
Get full text

The 1973 WHO and 2004 WHO grading systems are not equal in prediction of survival among stage T1 bladder cancer patients by Krajewski, W, Rodríguez-Faba, O, Breda, A, Pisano, F, Poletajew, S, Tukiendorf, A, Algaba, F, Zdrojowy, R, Kołodziej, A, Palou, J

“…INTRODUCTION AND OBJECTIVESThe aim of this study was to analyse prognostic impact of tumour histological grade on survival differences between primary G2 and…”
Get full text

17LBA Results from an open-label, randomized, controlled Phase 3 study investigating IMA901 multipeptide cancer vaccine in patients receiving sunitinib as first-line therapy for advanced/metastatic RCC by Rini, B, Stenzl, A, Zdrojowy, R, Kogan, M, Shkolnik, M, Oudard, S, Weikert, S, Bracarda, S, Crabb, S, Bedke, J, Ludwig, J, Maurer, D, Mendrzyk, R, Mahr, A, Fritsche, J, Weinschenk, T, Singh, H, Kirner, A, Reinhardt, C, Eisen, T

Get full text

Validation of the CUETO scoring model for predicting recurrence and progression in T1G3 urothelial carcinoma of the bladder by Krajewski, W., Rodríguez-Faba, O., Breda, A., Pisano, F., Poletajew, S., Tukiendorf, A., Zdrojowy, R., Kołodziej, A., Palou, J.

“…Various studies tried to validate Club Urológico Español de Tratamiento Oncológico (CUETO) tables, yet, none of this papers focused on the high and very high…”
Get full text

A large germline deletion in the Chek2 kinase gene is associated with an increased risk of prostate cancer by Cybulski, C, Wokołorczyk, D, Huzarski, T, Byrski, T, Gronwald, J, Górski, B, Dębniak, T, Masojć, B, Jakubowska, A, Gliniewicz, B, Sikorski, A, Stawicka, M, Godlewski, D, Kwias, Z, Antczak, A, Krajka, K, Lauer, W, Sosnowski, M, Sikorska-Radek, P, Bar, K, Klijer, R, Zdrojowy, R, Małkiewicz, B, Borkowski, A, Borkowski, T, Szwiec, M, Narod, S A, Lubiński, J

“…Background: Germline mutations in the Chek2 kinase gene (CHEK2) have been associated with a range of cancer types. Recently, a large deletion of exons 9 and 10…”
Get full text

The 1973 WHO and 2004 WHO grading systems are not equal in prediction of survival among stage T1 bladder cancer patients by Krajewski, W., Rodríguez-Faba, O., Breda, A., Pisano, F., Poletajew, S., Tukiendorf, A., Algaba, F., Zdrojowy, R., Kołodziej, A., Palou, J.

“…The aim of this study was to analyse prognostic impact of tumour histological grade on survival differences between primary G2 and G3 WHO1973 stage T1 tumours…”
Get full text

A personalised approach to prostate cancer screening based on genotyping of risk founder alleles by Cybulski, C, Wokołorczyk, D, Kluźniak, W, Kashyap, A, Gołąb, A, Słojewski, M, Sikorski, A, Puszyński, M, Soczawa, M, Borkowski, T, Borkowski, A, Antczak, A, Przybyła, J, Sosnowski, M, Małkiewicz, B, Zdrojowy, R, Domagała, P, Piotrowski, K, Menkiszak, J, Krzystolik, K, Gronwald, J, Jakubowska, A, Górski, B, Dębniak, T, Masojć, B, Huzarski, T, Muir, K R, Lophatananon, A, Lubiński, J, Narod, S A

“…Background: To evaluate whether genotyping for 18 prostate cancer founder variants is helpful in identifying high-risk individuals and for determining optimal…”
Get full text

UP-01.044 Ileal Orthotopic Bladder Replacement Without Stenting of Ureterointestinal Anastomosis: 10 Years' Observation by Kowal, P, Lorenz, J, Dembowski, J, Szydelko, T, Kolodziej, A, Kasprzak, J, Niezgoda, T, Wozniak, P, Malkiewicz, B, Zdrojowy, R

Get full text

MP-08.25: Prevalence of symptoms and effectiveness of symptom relief for patients with advanced prostate cancer by Wozniak, S, Zdrojowy, R, Kolodziej, A

Get full text

POS-03.54: Penile fracture: no difference in treatment in two European centres by Wozniak, S, Zdrojowy, R, Debinski, P, Kuppurajan, N, Kolodziej, A, Kowal, P, Ilo, D

Get full text

Treatment of high‐risk superficial bladder cancer with maintenance bacille Calmette‐Guérin therapy: preliminary results by Kolodziej, A., Dembowski, J., Zdrojowy, R., Wozniak, P., Lorenz, J.

“…Objective To evaluate, in a prospective study, the effects and results of maintenance therapy with bacille Calmette‐Gue´rin (BCG) in treating patients with…”
Get full text

Diagnostic value of sentinel lymph node technique in patient with invasive bladder cancer – Results from a prospective study by Malkiewicz, B., Kiełb, P., Jędrzejuk, D., Krajewski, W., Nowak, Ł., Bolanowski, M., Zdrojowy, R.

Get full text

CTLA-4 and CD28 genes' polymorphisms and renal cell carcinoma susceptibility in the Polish population - a prospective study by Tupikowski, K., Partyka, A., Kolodziej, A., Dembowski, J., Debinski, P., Halon, A., Zdrojowy, R., Frydecka, I., Karabon, L.

“…Polymorphisms in co‐stimulatory genes are associated with susceptibility to several malignances such as breast cancer, cervical cancer and chronic lymphocytic…”
Get full text

Influence of the virtual reality devices on pain and anxiety in patients undergoing cystoscopy performed under local anesthesia by Łuczak, M., Krajewski, W., Nowak, Ł., Chorbińska, J., Galik, K., Kiełb, P., Tukiendorf, A., Kościelska-Kasprzak, K., Małkiewicz, B., Zdrojowy, R.

Get full text

The influence of bilateral orchiectomy on volume changes of the prostate in men with advanced prostatic cancer--the predictive value by Zdrojowy, R

“…The changes of prostatic volume were evaluated in 84 men with adenocarcinoma of the prostate treated by bilateral orchiectomy. In every case the greatest…”
Get full text

An inherited NBN mutation is associated with poor prognosis prostate cancer by Cybulski, C, Wokołorczyk, D, Kluźniak, W, Jakubowska, A, Górski, B, Gronwald, J, Huzarski, T, Kashyap, A, Byrski, T, Dębniak, T, Gołąb, A, Gliniewicz, B, Sikorski, A, Świtała, J, Borkowski, T, Borkowski, A, Antczak, A, Wojnar, Ł, Przybyła, J, Sosnowski, M, Małkiewicz, B, Zdrojowy, R, Sikorska-Radek, P, Matych, J, Wilkosz, J, Różański, W, Kiś, J, Bar, K, Bryniarski, P, Paradysz, A, Jersak, K, Niemirowicz, J, Słupski, P, Jarzemski, P, Skrzypczyk, M, Dobruch, J, Domagała, P, Narod, S A, Lubiński, J

“…Background: To establish the contribution of eight founder alleles in three DNA damage repair genes ( BRCA1 , CHEK2 and NBS1 ) to prostate cancer in Poland,…”
Get full text

P110 The assessment of therapeutic practice of urologists and clinical oncologists and the pattern of referrals in the treatment of metastatic Castration-Resistant Prostate Cancer (mCRPC) in Poland (ProSTandard Registry) by Skoneczna, I, Zdrojowy, R, Sosnowski, M, Poborski, W, Oczkowski, P, Pustelnik, P, Nowaczyk, M, Narożański, W

Get full text